5.210USD-4.58%Mkt Cap: 6.62M USDP/E: —Last update: 2026-05-26
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed …
Industry Peers
Diagnostics & Research166.94BUSDP/E 24.7
122.72BUSDP/E 33.6
44.05BUSDP/E 41.1
34.33BCHFP/E 37.8
33.46BUSDP/E 43.3
32.69BUSDP/E 25.5
28.46BUSD—
27.28BUSDP/E 20.3
Indicators:|
Key Statistics
Company
Market Cap6.62M USD
Enterprise Value6.90M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-7.03M USD
Revenue/Share—
Last Price5.210 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees9
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.34
PEG—
EV/EBITDA-1.07
EV/Revenue—
P/S—
P/B3.52
EPS (TTM)-8.16
EPS (Forward)-4.00
52W Range
2.91525% of range11.96
52W High11.96 USD
52W Low2.915 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-310.93%
ROA-182.35%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.18M USD
CapEx (TTM)3.02M USD
FCF Margin—
FCF Yield-89.38%
Net Debt104.74K USD
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.22
Current Ratio0.64
Quick Ratio0.43
Book Value/Sh1.519 USD
Cash/Share0.2810 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:35
Split DateNov 7, 2024
Analyst Consensus
Rating—
Target (Mean)27.00 USD
Target Range27.00 USD – 27.00 USD
# Analysts1
Ownership
Shares Out.1.27M
Float1.20M
Insiders14.21%
Institutions16.19%
Short Interest
Short Ratio1.9d
Short % Float3.16%
Short % Out.2.98%
Shares Short36.95K
Short (prev mo.)52.70K
Technical
SMA 504.771 (+9.2%)
SMA 2004.855 (+7.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)17.57K
Avg Vol (10d)19.54K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—